The Korean Society for Neuro-Oncology (KSNO) Guideline for Adult Diffuse Midline Glioma: Version 2021.1

BACKGROUND: There have been no guidelines for the management of adult patients with diffuse midline glioma (DMG), H3K27M-mutant in Korea since the 2016 revised WHO classification newly defined this disease entity. Thus, the Korean Society for Neuro-Oncology (KSNO), a multidisciplinary academic socie...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Brain Tumor Res Treat
Main Authors: Yoon, Hong In, Wee, Chan Woo, Kim, Young Zoon, Seo, Youngbeom, Im, Jung Ho, Dho, Yun-Sik, Kim, Kyung Hwan, Hong, Je Beom, Park, Jae-Sung, Choi, Seo Hee, Kim, Min-Sung, Moon, Jangsup, Hwang, Kihwan, Park, Ji Eun, Cho, Jin Mo, Yoon, Wan-Soo, Kim, Se Hoon, Kim, Young Il, Kim, Ho Sung, Sung, Kyoung Su, Song, Jin Ho, Lee, Min Ho, Han, Myung-Hoon, Lee, Se-Hoon, Chang, Jong Hee, Lim, Do Hoon, Park, Chul-Kee, Lee, Youn Soo, Gwak, Ho-Shin
פורמט: Artigo
שפה:Inglês
יצא לאור: The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology 2021
נושאים:
Original Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC8082289/
https://ncbi.nlm.nih.gov/pubmed/33913265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14791/btrt.2021.9.e8
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים